Skip to main content
Clinical Trials/NCT05950620
NCT05950620
Recruiting
Not Applicable

Pilot and Feasibility Project to Establish a Childhood Nutrition and Health Clinic Managing Weight and Obesity Complications in a Primary Care Pediatric Practice

Oregon Health and Science University2 sites in 1 country400 target enrollmentJuly 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity, Childhood
Sponsor
Oregon Health and Science University
Enrollment
400
Locations
2
Primary Endpoint
Change in body height
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This project aims to move what is currently a specialty-care model for the management of obesity of children and adolescents into the primary care setting.

Detailed Description

The goal of this project is to create a sustainable clinical model in the primary care setting that improves nutritional health, lessens obesity, and addresses weight-related complications of children and adolescents to reduce risk for metabolic disease in later life. The primary objectives include tracking changes in BMI (both absolute and percentile) and levels of hemoglobin A1c, liver enzymes (AST, ALT levels), and lipids in patients seen in a primary care setting by a general pediatrician board-certified in obesity medicine. Secondary objectives include tracking patient adherence, follow-up, and retention.

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
June 30, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jonathan Purnell

Professor

Oregon Health and Science University

Eligibility Criteria

Inclusion Criteria

  • Children with obesity (BMI \> 30 kg/m2 or \> 95th percentile) or in need of weight management of unwanted weight gain.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in body height

Time Frame: Baseline to follow-up (1-3 years)

Body height in meters

Impact on fatty liver

Time Frame: Baseline to follow-up (1-3 years)

Levels of liver enzymes ALT, AST

Impact on glucose control

Time Frame: Baseline to follow-up (1-3 years)

Hemoglobin A1c levels

Impact on lipid levels

Time Frame: Baseline to follow-up (1-3 years)

Levels of total, LDL, HDL, and non-HDL cholesterol. Triglycerides.

Change in body weight

Time Frame: Baseline to follow-up (1-3 years)

Body weight in kg

Change in BMI

Time Frame: Baseline to follow-up (1-3 years)

BMI will be calculated using the formula: kg weight / m2 height. Will be in both absolute and percentile for age

Secondary Outcomes

  • Patient follow-up metrics(Baseline to follow-up (1-3 years))

Study Sites (2)

Loading locations...

Similar Trials